Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT01109394
- Status
- Recruiting
Conditions
- Endocrine Tumors
- Neuroblastoma
- Renal Cancer
- Retinoblastoma
- Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Weeks - N/A
- Healthy Volunteers
- Accepted
Study Details
Background: \- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue repository to collect and store blood, serum, tissue, urine, or tumors of children who have cancer or adults who have common childhood cancers. To develop this repository, additional samples will be collected from children and adults who have been diagnosed with common childhood cancers such as leukemia and tumors of the central nervous system. Objectives: \- To collect and store blood, serum, tissue, urine, or tumor samples of children who have cancer or adults who have common childhood cancers. Eligibility: * Individuals who have been diagnosed with a common childhood cancer (e.g., leukemia) regardless of patient age. * Children, adolescents, and adults who have been diagnosed with a type of cancer more commonly found in adults. Design: * Extra blood, serum (the liquid part of blood), tissue, urine, or tumor samples will be collected from participants at a time when sampling is required for medical care or as part of a research study. * No additional procedures will be performed for the sole purpose of obtaining additional tumor tissue, aside from what is required for clinical care.
Key Dates
- Start date
- Apr 21, 2010
- Status verified
- Sep 2025
Study Design
- Enrollment
- 6,035 participants (estimated)
Arms
- Arm: 1/Cohort 1Adult or Pediatric subjects, with any malignancy, pre-malignancy, suspected malignancy, family history of malignancy, or without malignancy undergoing surgery or well visit.
- Arm: 2/Cohort 2Human samples, specimens and data collected on IRB approved protocols that are now closed
- Arm: 3/Cohort 3Parent/caregiver of a participating pediatric or adult subject who is being treated for, or who has previously been treated for any form of pediatric cancer.
Primary Outcome Measure
tissue analysis [ Time Frame: ongoing ]
Central Contacts
- Donna B Bernstein, R.N.(240) 760-6189
- Rosandra N Kaplan, M.D.(240) 760-6198
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | - |
| Children's Hospital of Orange County (CHOC Children's) | Orange | Florida | 92613 | - |
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
| Tisch Cancer Institute, Mount Sinai Medical Center | New York | New York | 10029-0574 | - |
| Carolinas Medical Center/Levine Children's Hospital | Charlotte | North Carolina | 28203 | - |
Find similar trials in Washington D.C., DC
Related Studies
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant DiseaseRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or ParagangliomaPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Novel Biochemical and Molecular Determinants for Soft Tissue SarcomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey